Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study.
Saved in:
| Title: | Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study. |
|---|---|
| Authors: | Jakacki RI; Children's Hospital of Pittsburgh, University of Pittsburgh, 4401 Penn Ave., Pittsburgh, PA, 15224, USA. regina.jakacki@astrazeneca.com.; AstraZeneca, One Medimmune Way, Gaithersburg, MD, 20878, USA. regina.jakacki@astrazeneca.com., Foley MA; Astellas Pharma Global Development, 1 Astellas Way, Northbrook, IL, 60062, USA., Horan J; Novella Clinical, 4840 Pearl E Cir # 100, Boulder, CO, 80301, USA., Wang J; Astellas Pharma Global Development, 1 Astellas Way, Northbrook, IL, 60062, USA., Kieran MW; Pediatric Neuro-Oncology, Dana-Farber Cancer Institution, Boston Children's Hospital, 450 Brookline Ave., D-3154, Boston, MA, 02215, USA., Bowers DC; Department of Pediatrics, University of Texas Southwestern Medical School, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA., Bouffet E; The Hospital for Sick Kids, 555 University Avenue, Toronto, ON, M5G 1X8, Canada., Zacharoulis S; The Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK., Gill SC; Astellas Pharma Global Development, 1 Astellas Way, Northbrook, IL, 60062, USA. |
| Source: | Journal of neuro-oncology [J Neurooncol] 2016 Aug; Vol. 129 (1), pp. 131-8. Date of Electronic Publication: 2016 Jun 10. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27287856 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jakacki+RI%22">Jakacki RI</searchLink>; Children's Hospital of Pittsburgh, University of Pittsburgh, 4401 Penn Ave., Pittsburgh, PA, 15224, USA. regina.jakacki@astrazeneca.com.; AstraZeneca, One Medimmune Way, Gaithersburg, MD, 20878, USA. regina.jakacki@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22Foley+MA%22">Foley MA</searchLink>; Astellas Pharma Global Development, 1 Astellas Way, Northbrook, IL, 60062, USA.<br /><searchLink fieldCode="AU" term="%22Horan+J%22">Horan J</searchLink>; Novella Clinical, 4840 Pearl E Cir # 100, Boulder, CO, 80301, USA.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Astellas Pharma Global Development, 1 Astellas Way, Northbrook, IL, 60062, USA.<br /><searchLink fieldCode="AU" term="%22Kieran+MW%22">Kieran MW</searchLink>; Pediatric Neuro-Oncology, Dana-Farber Cancer Institution, Boston Children's Hospital, 450 Brookline Ave., D-3154, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Bowers+DC%22">Bowers DC</searchLink>; Department of Pediatrics, University of Texas Southwestern Medical School, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA.<br /><searchLink fieldCode="AU" term="%22Bouffet+E%22">Bouffet E</searchLink>; The Hospital for Sick Kids, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.<br /><searchLink fieldCode="AU" term="%22Zacharoulis+S%22">Zacharoulis S</searchLink>; The Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, UK.<br /><searchLink fieldCode="AU" term="%22Gill+SC%22">Gill SC</searchLink>; Astellas Pharma Global Development, 1 Astellas Way, Northbrook, IL, 60062, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228309335%22">Journal of neuro-oncology</searchLink> [J Neurooncol] 2016 Aug; Vol. 129 (1), pp. 131-8. <i>Date of Electronic Publication: </i>2016 Jun 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309335 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7373 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220167594X%22">0167594X </searchLink><i>NLM ISO Abbreviation: </i>J Neurooncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27287856 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11060-016-2155-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 131 Titles: – TitleFull: Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jakacki RI – PersonEntity: Name: NameFull: Foley MA – PersonEntity: Name: NameFull: Horan J – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Kieran MW – PersonEntity: Name: NameFull: Bowers DC – PersonEntity: Name: NameFull: Bouffet E – PersonEntity: Name: NameFull: Zacharoulis S – PersonEntity: Name: NameFull: Gill SC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2016 Aug Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1573-7373 Numbering: – Type: volume Value: 129 – Type: issue Value: 1 Titles: – TitleFull: Journal of neuro-oncology Type: main |
| ResultId | 1 |
